Spyre Therapeutics (SYRE) is up 24.2%, or $12.41 to $63.70.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYRE:
- Spyre Therapeutics rises 28.4%
- Spyre Therapeutics Reports Positive Phase 2 SKYLINE Results
- Spyre Therapeutics reports SPY001 meets primary endpoint
- Damora names Peter Harwin chairman, appoints Spyre Therapeutics CEO to board
- Spyre Therapeutics Completes First-in-Human Study of SPY001-001, De-risking Early Pipeline